Research progress on glycolytic reprogramming in ophthalmic diseases

Area of Science:

• Ophthalmology
• Metabolic pathways
• Cellular biology

Background:

• The retina is a highly energy-demanding tissue with metabolism dominated by aerobic glycolysis.
• Aerobic glycolysis is essential for normal retinal cell function.
• Metabolic dysregulation is implicated in various ocular diseases.

Purpose of the Study:

• To review the mechanisms of metabolic reprogramming in ocular diseases.
• To identify and discuss potential therapeutic targets for these conditions.
• To highlight areas needing further investigation in ophthalmic metabolic research.

Main Methods:

• Literature review of studies on retinal metabolism and ocular diseases.
• Analysis of mechanisms underlying metabolic reprogramming.
• Identification of therapeutic targets based on current research.

Main Results:

• Metabolic reprogramming, particularly aerobic glycolysis, is a key pathological factor in retinal degeneration, uveal melanoma, and glaucoma.
• Specific metabolic pathways and regulatory mechanisms are altered in disease states.
• Several potential therapeutic targets have been identified.

Conclusions:

• Metabolic reprogramming plays a significant role in the pathogenesis of major ocular diseases.
• Targeting metabolic pathways presents a promising therapeutic strategy.
• Further research is required to fully elucidate regulatory mechanisms and develop novel treatments.